AURORA, Ontario, Sept. 8 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. today announced that it has closed its previously announced private placement of 6,625,000 units at $2.05 per unit.
The securities offered will not be and have not been registered under the United States Securities Act of 1933, as amended, or the securities laws of any state of the United States, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Helix BioPharma Corp.